Debiopharm secured $5.76M from CARB-X to progress the preclinical development of Debio 1453, an antibiotic targeting drug-resistant Neisseria gonorrhoeae infections.
Amount Raised
$5.76 Million
Round Type
Funding Round
LausanneBiotechnologyHealth CareTherapeuticsInvestors
Description
Debiopharm has received additional funding from CARB-X for the development of Debio 1453, an antibiotic aimed at combating drug-resistant N. gonorrhoeae infections. This funding will aid in essential preclinical research and preparation for clinical trials.
Quick answer
Debiopharm raised $5.76 Million in a Funding Round round, dated November 21, 2024. Investors: Carb X. Debiopharm is based in Lausanne, Vaud, Switzerland.
- How much did Debiopharm raise?
- Debiopharm raised $5.76 Million in a Funding Round round on November 21, 2024.
- Who invested in Debiopharm?
- Carb X is named as investors in this round.
- What does Debiopharm do?
- Debiopharm is a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases.
- Where is Debiopharm based and how big is it?
- Debiopharm is based in Lausanne, Vaud, Switzerland. Fundz records about 494 employees.
- Who are the decision-makers at Debiopharm?
- Fundz holds 1 contact at Debiopharm. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Debiopharm that raised within 45 days of this round, from Fundz verified event records.
- Os Therapies raised $7.1M on December 31, 2024.
- Os Therapies raised $6M (Post-IPO Equity) on December 31, 2024.
- Hinge Bio raised $31M on December 31, 2024.
- AusperBio raised $73M (Series B) on December 27, 2024.
- Phio Pharmaceuticals raised $30K (Seed) on December 24, 2024.
- GEMMABio raised $34M (Series A) on December 23, 2024.
Who to call at Debiopharm, and when
A new round usually means Debiopharm is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Debiopharm raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Debiopharm, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Debiopharm. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Debiopharm raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Debiopharm raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.